1	Hypothesis	Hypothesis	B-NP	NN	O	4	NMOD	0
2	:	:	O	:	O	1	P	0
3	Induced	Induce	B-NP	VBN	O	4	NMOD	17	Induced
4	angiogenesis	angiogenesis	I-NP	NN	O	13	SUB	3	angiogenesis
5	after	after	B-PP	IN	O	4	NMOD	0
6	surgery	surgery	B-NP	NN	O	5	PMOD	19	surgery
7	in	in	B-PP	IN	O	6	NMOD	0
8	premenopausal	premenopausal	B-NP	JJ	O	12	NMOD	0
9	node-positive	node-positive	I-NP	JJ	O	12	NMOD	0
10	breast	breast	I-NP	NN	O	12	NMOD	0
11	cancer	cancer	I-NP	NN	O	12	NMOD	0
12	patients	patient	I-NP	NNS	O	7	PMOD	0
13	is	be	B-VP	VBZ	O	0	ROOT	0
14	a	a	B-NP	DT	O	17	NMOD	0
15	major	major	I-NP	JJ	O	17	NMOD	0
16	underlying	underlying	I-NP	JJ	O	17	NMOD	0
17	reason	reason	I-NP	NN	O	13	PRD	0
18	why	why	B-ADVP	WRB	O	17	NMOD	0
19	adjuvant	adjuvant	B-NP	JJ	O	20	NMOD	0
20	chemotherapy	chemotherapy	I-NP	NN	O	21	SUB	19	chemotherapy
21	works	work	B-VP	VBZ	O	18	SBAR	0
22	particularly	particularly	B-ADVP	RB	O	21	VMOD	0
23	well	well	I-ADVP	RB	O	22	AMOD	0
24	for	for	B-PP	IN	O	22	AMOD	0
25	those	those	B-NP	DT	O	26	NMOD	0
26	patients	patient	I-NP	NNS	O	24	PMOD	0
27	.	.	O	.	O	13	P	0

1	BACKGROUND	BACKGROUND	B-NP	NN	O	4	VMOD	0
2	:	:	O	:	O	4	P	0
3	We	We	B-NP	PRP	O	4	SUB	0
4	suggest	suggest	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	surgical	surgical	B-NP	JJ	O	7	NMOD	0
7	extirpation	extirpation	I-NP	NN	O	15	SUB	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	primary	primary	B-NP	JJ	O	11	NMOD	0
10	breast	breast	I-NP	NN	O	11	NMOD	0
11	cancer	cancer	I-NP	NN	O	8	PMOD	0
12	among	among	B-PP	IN	O	7	NMOD	0
13	other	other	B-NP	JJ	O	14	NMOD	0
14	effects	effect	I-NP	NNS	O	12	PMOD	0
15	accelerates	accelerate	B-VP	VBZ	O	5	SBAR	0
16	relapse	relapse	B-NP	NN	O	15	OBJ	0
17	for	for	B-PP	IN	O	16	NMOD	0
18	some	some	B-NP	DT	O	21	NMOD	0
19	premenopausal	premenopausal	I-NP	JJ	O	21	NMOD	0
20	node-positive	node-positive	I-NP	JJ	O	21	NMOD	0
21	patients	patient	I-NP	NNS	O	17	PMOD	0
22	.	.	O	.	O	4	P	0

1	These	These	B-NP	DT	O	3	NMOD	0
2	accelerated	accelerated	I-NP	JJ	O	3	NMOD	0
3	relapses	relapse	I-NP	NNS	O	4	SUB	0
4	occur	occur	B-VP	VBP	O	0	ROOT	0
5	within	within	B-PP	IN	O	4	VMOD	0
6	10	10	B-NP	CD	O	7	NMOD	0
7	months	month	I-NP	NNS	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	surgery	surgery	B-NP	NN	O	8	PMOD	19	surgery
10	for	for	B-PP	IN	O	7	NMOD	0
11	untreated	untreated	B-NP	JJ	O	12	NMOD	19	untreated
12	patients	patient	I-NP	NNS	O	10	PMOD	0
13	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	mechanism	mechanism	I-NP	NN	O	4	SUB	0
3	proposed	propose	B-VP	VBN	O	2	NMOD	0
4	is	be	B-VP	VBZ	O	0	ROOT	0
5	a	a	B-NP	DT	O	6	NMOD	0
6	stimulation	stimulation	I-NP	NN	O	4	PRD	17	stimulation
7	of	of	B-PP	IN	O	6	NMOD	0
8	angiogenesis	angiogenesis	B-NP	NN	O	7	PMOD	3	angiogenesis
9	for	for	B-PP	IN	O	6	NMOD	0
10	distant	distant	B-NP	JJ	B-protein	12	NMOD	0
11	dormant	dormant	I-NP	JJ	I-protein	12	NMOD	0
12	micrometastases	micrometastas	I-NP	NNS	I-protein	9	PMOD	0
13	.	.	O	.	O	4	P	0

1	This	This	B-NP	DT	O	2	SUB	0
2	has	have	B-VP	VBZ	O	0	ROOT	0
3	been	be	I-VP	VBN	O	2	VC	0
4	suggested	suggest	I-VP	VBN	O	3	VC	0
5	as	as	B-PP	IN	O	4	VMOD	0
6	one	one	B-NP	CD	O	11	SUB	0
7	of	of	B-PP	IN	O	6	NMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	mechanisms	mechanism	I-NP	NNS	O	7	PMOD	0
10	to	to	B-VP	TO	O	11	VMOD	0
11	explain	explain	I-VP	VB	O	5	SBAR	0
12	the	the	B-NP	DT	O	14	NMOD	0
13	mammography	mammography	I-NP	NN	O	14	NMOD	0
14	paradox	paradox	I-NP	NN	O	11	OBJ	0
15	for	for	B-PP	IN	O	14	NMOD	0
16	women	woman	B-NP	NNS	O	15	PMOD	0
17	aged	age	B-VP	VBN	O	16	NMOD	0
18	40-49	40-49	B-NP	CD	O	19	NMOD	0
19	years	year	I-NP	NNS	O	17	AMOD	0
20	.	.	O	.	O	2	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	could	could	B-VP	MD	O	21	VMOD	0
3	imagine	imagine	I-VP	VB	O	2	VC	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	it	it	B-NP	PRP	O	7	SUB	0
6	also	also	B-ADVP	RB	O	7	VMOD	0
7	plays	play	B-VP	VBZ	O	4	SBAR	0
8	a	a	B-NP	DT	O	9	NMOD	0
9	role	role	I-NP	NN	O	7	OBJ	0
10	in	in	B-PP	IN	O	7	VMOD	0
11	adjuvant	adjuvant	B-NP	JJ	O	13	NMOD	0
12	chemotherapy	chemotherapy	I-NP	NN	O	13	NMOD	19	chemotherapy
13	effectiveness	effectiveness	I-NP	NN	O	10	PMOD	0
14	since	since	B-PP	IN	O	7	VMOD	0
15	,	,	O	,	O	14	P	0
16	perhaps	perhaps	B-ADVP	RB	O	14	DEP	0
17	not	not	B-ADVP	RB	O	16	AMOD	0
18	coincidentally	coincidentally	I-ADVP	RB	O	17	AMOD	0
19	,	,	O	,	O	7	P	0
20	this	this	B-NP	DT	O	7	OBJ	0
21	is	be	B-VP	VBZ	O	0	ROOT	0
22	most	most	B-ADJP	RBS	O	23	AMOD	0
23	beneficial	beneficial	I-ADJP	JJ	O	21	PRD	0
24	for	for	B-PP	IN	O	23	AMOD	0
25	premenopausal	premenopausal	B-NP	JJ	O	27	NMOD	0
26	node-positive	node-positive	I-NP	JJ	O	27	NMOD	0
27	patients	patient	I-NP	NNS	O	24	PMOD	0
28	.	.	O	.	O	21	P	0

1	HYPOTHESIS	HYPOTHESIS	B-NP	NN	O	4	VMOD	0
2	:	:	O	:	O	4	P	0
3	We	We	B-NP	PRP	O	4	SUB	0
4	speculate	speculate	B-VP	VBP	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	there	there	B-NP	EX	O	7	SUB	0
7	is	be	B-VP	VBZ	O	5	SBAR	0
8	a	a	B-NP	DT	O	9	NMOD	0
9	burst	burst	I-NP	NN	O	7	PRD	17	burst
10	of	of	B-PP	IN	O	9	NMOD	0
11	angiogenesis	angiogenesis	B-NP	NN	O	10	PMOD	3	angiogenesis
12	of	of	B-PP	IN	O	11	NMOD	0
13	distant	distant	B-NP	JJ	B-protein	15	NMOD	0
14	dormant	dormant	I-NP	JJ	I-protein	15	NMOD	0
15	micrometastases	micrometastas	I-NP	NNS	I-protein	12	PMOD	0
16	after	after	B-PP	IN	O	11	NMOD	0
17	surgery	surgery	B-NP	NN	O	16	PMOD	19	surgery
18	in	in	B-PP	IN	O	17	NMOD	0
19	approximately	approximately	B-NP	RB	O	21	NMOD	0
20	20	20	I-NP	CD	O	19	AMOD	0
21	%	%	I-NP	NN	O	18	PMOD	0
22	of	of	B-PP	IN	O	21	NMOD	0
23	premenopausal	premenopausal	B-NP	JJ	O	25	NMOD	0
24	node-positive	node-positive	I-NP	JJ	O	25	NMOD	0
25	patients	patient	I-NP	NNS	O	22	PMOD	0
26	.	.	O	.	O	4	P	0

1	We	We	B-NP	PRP	O	3	SUB	0
2	also	also	B-ADVP	RB	O	3	VMOD	0
3	speculate	speculate	B-VP	VBP	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	this	this	B-NP	DT	O	6	SUB	0
6	synchronizes	synchronize	B-VP	VBZ	O	4	SBAR	0
7	them	them	B-NP	PRP	O	6	OBJ	0
8	into	into	B-PP	IN	O	6	VMOD	0
9	a	a	B-NP	DT	O	13	NMOD	0
10	temporal	temporal	I-NP	JJ	O	12	AMOD	0
11	highly	highly	I-NP	RB	O	12	AMOD	0
12	chemosensitive	chemosensitive	I-NP	JJ	O	13	NMOD	0
13	state	state	I-NP	NN	O	8	PMOD	0
14	and	and	O	CC	O	6	VMOD	0
15	is	be	B-VP	VBZ	O	6	VMOD	0
16	the	the	B-NP	DT	O	18	NMOD	0
17	underlying	underlie	I-NP	VBG	O	18	NMOD	0
18	reason	reason	I-NP	NN	O	15	PRD	0
19	why	why	B-ADVP	WRB	O	18	NMOD	0
20	adjuvant	adjuvant	B-NP	JJ	O	21	NMOD	0
21	chemotherapy	chemotherapy	I-NP	NN	O	22	SUB	19	chemotherapy
22	works	work	B-VP	VBZ	O	19	SBAR	0
23	particularly	particularly	B-ADVP	RB	O	22	VMOD	0
24	well	well	I-ADVP	RB	O	23	AMOD	0
25	for	for	B-PP	IN	O	23	AMOD	0
26	that	that	B-NP	DT	O	28	NMOD	0
27	patient	patient	I-NP	NN	O	28	NMOD	0
28	category	category	I-NP	NN	O	25	PMOD	0
29	.	.	O	.	O	3	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	this	this	B-NP	DT	O	4	SUB	0
4	may	may	B-VP	MD	O	0	ROOT	0
5	explain	explain	I-VP	VB	O	4	VC	0
6	why	why	B-ADVP	WRB	O	5	VMOD	0
7	cancer	cancer	B-NP	NN	O	11	SUB	0
8	in	in	B-PP	IN	O	7	NMOD	0
9	younger	young	B-NP	JJR	O	10	NMOD	0
10	patients	patient	I-NP	NNS	O	8	PMOD	0
11	is	be	B-VP	VBZ	O	6	SBAR	0
12	more	more	B-ADVP	RBR	O	13	AMOD	0
13	often	often	I-ADVP	RB	O	11	PRD	0
14	'aggressive	'aggressive	B-ADVP	JJ	O	13	AMOD	0
15	'	'	O	''	O	13	AMOD	0
16	.	.	O	.	O	4	P	0

1	TESTING	TESTING	B-VP	VBG	O	13	VMOD	0
2	THE	THE	B-NP	DT	O	3	NMOD	0
3	HYPOTHESIS	HYPOTHESIS	I-NP	NN	O	1	OBJ	0
4	:	:	O	:	O	1	P	0
5	Stimulation	Stimulation	B-NP	NN	O	13	SUB	17	Stimulation
6	of	of	B-PP	IN	O	5	NMOD	0
7	dormant	dormant	B-NP	JJ	B-protein	8	NMOD	0
8	micrometastases	micrometastas	I-NP	NNS	I-protein	6	PMOD	0
9	by	by	B-PP	IN	O	5	NMOD	0
10	primary	primary	B-NP	JJ	O	12	NMOD	0
11	tumor	tumor	I-NP	NN	O	12	NMOD	0
12	removal	removal	I-NP	NN	O	9	PMOD	19	removal
13	is	be	B-VP	VBZ	O	0	ROOT	0
14	known	know	I-VP	VBN	O	13	VC	0
15	to	to	I-VP	TO	O	16	VMOD	0
16	occur	occur	I-VP	VB	O	14	VMOD	0
17	in	in	B-PP	IN	O	16	VMOD	0
18	animal	animal	B-NP	NN	O	19	NMOD	0
19	models	model	I-NP	NNS	O	17	PMOD	0
20	.	.	O	.	O	13	P	0

1	However	However	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	need	need	B-VP	VBP	O	0	ROOT	0
5	to	to	I-VP	TO	O	6	VMOD	0
6	determine	determine	I-VP	VB	O	4	VMOD	0
7	whether	whether	B-SBAR	IN	O	6	VMOD	0
8	it	it	B-NP	PRP	O	9	SUB	0
9	happens	happen	B-VP	VBZ	O	7	SBAR	0
10	in	in	B-PP	IN	O	9	VMOD	0
11	breast	breast	B-NP	NN	O	12	NMOD	0
12	cancer	cancer	I-NP	NN	O	10	PMOD	0
13	.	.	O	.	O	4	P	0

1	Transient	Transient	B-NP	JJ	O	3	NMOD	0
2	circulating	circulate	I-NP	VBG	O	3	NMOD	0
3	levels	level	I-NP	NNS	O	15	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	angioactive	angioactive	B-NP	JJ	B-protein	6	NMOD	3	angioactive
6	molecules	molecule	I-NP	NNS	I-protein	11	NMOD	0
7	and	and	O	CC	O	11	NMOD	0
8	serial	serial	B-NP	JJ	O	11	NMOD	0
9	high-resolution	high-resolution	I-NP	JJ	O	11	NMOD	0
10	imaging	imaging	I-NP	NN	O	11	NMOD	0
11	studies	study	I-NP	NNS	O	4	PMOD	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	focal	focal	B-NP	JJ	O	14	NMOD	0
14	angiogenesis	angiogenesis	I-NP	NN	O	12	PMOD	3	angiogenesis
15	might	might	B-VP	MD	O	0	ROOT	0
16	help	help	I-VP	VB	O	15	VC	0
17	.	.	O	.	O	15	P	0

1	IMPLICATIONS	IMPLICATIONS	B-NP	NNS	O	20	NMOD	0
2	:	:	O	:	O	1	P	0
3	Short-course	Short-course	B-NP	JJ	O	5	NMOD	0
4	cytotoxic	cytotoxic	I-NP	JJ	O	5	NMOD	0
5	chemotherapy	chemotherapy	I-NP	NN	O	8	SUB	0
6	after	after	B-SBAR	IN	O	5	NMOD	0
7	surgery	surgery	B-NP	NN	O	6	PMOD	0
8	has	have	B-VP	VBZ	O	20	VMOD	0
9	probably	probably	I-VP	RB	O	8	VMOD	0
10	reached	reach	I-VP	VBN	O	8	VMOD	0
11	its	its	B-NP	PRP$	O	12	NMOD	0
12	zenith	zenith	I-NP	NN	O	10	OBJ	0
13	,	,	O	,	O	20	P	0
14	and	and	O	CC	O	16	NMOD	0
15	other	other	B-NP	JJ	O	16	NMOD	0
16	strategies	strategy	I-NP	NNS	O	20	NMOD	0
17	,	,	O	,	O	20	P	0
18	perhaps	perhaps	B-NP	RB	O	20	NMOD	0
19	antiangiogenic	antiangiogenic	I-NP	JJ	O	20	NMOD	3	angiogenic
20	methods	method	I-NP	NNS	O	22	SUB	0
21	,	,	O	,	O	20	P	0
22	are	be	B-VP	VBP	O	0	ROOT	0
23	needed	need	I-VP	VBN	O	22	VC	0
24	to	to	B-VP	TO	O	26	VMOD	0
25	successfully	successfully	I-VP	RB	O	26	VMOD	0
26	treat	treat	I-VP	VB	O	23	VMOD	19	treat
27	more	more	B-NP	JJR	O	28	NMOD	0
28	patients	patient	I-NP	NNS	O	26	OBJ	0
29	.	.	O	.	O	22	P	0

1	In	In	B-PP	IN	O	6	VMOD	0
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	6	P	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	hypothesis	hypothesis	I-NP	NN	O	6	SUB	0
6	predicts	predict	B-VP	VBZ	O	0	ROOT	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	early	early	B-NP	JJ	O	9	NMOD	0
9	detection	detection	I-NP	NN	O	23	SUB	0
10	,	,	O	,	O	9	P	0
11	which	which	B-NP	WDT	O	9	NMOD	0
12	is	be	B-VP	VBZ	O	11	SBAR	0
13	designed	design	I-VP	VBN	O	12	VC	0
14	to	to	I-VP	TO	O	15	VMOD	0
15	find	find	I-VP	VB	O	13	VMOD	0
16	more	more	B-NP	JJR	O	17	NMOD	0
17	patients	patient	I-NP	NNS	O	15	OBJ	0
18	without	without	B-PP	IN	O	17	NMOD	0
19	involved	involve	B-NP	VBN	O	21	NMOD	0
20	lymph	lymph	I-NP	NN	O	21	NMOD	0
21	nodes	node	I-NP	NNS	O	18	PMOD	0
22	,	,	O	,	O	9	P	0
23	may	may	B-VP	MD	O	7	SBAR	0
24	not	not	I-VP	RB	O	23	VMOD	0
25	be	be	I-VP	VB	O	23	VC	0
26	a	a	B-NP	DT	O	28	NMOD	0
27	synergistic	synergistic	I-NP	JJ	O	28	NMOD	0
28	strategy	strategy	I-NP	NN	O	25	PRD	0
29	with	with	B-PP	IN	O	28	NMOD	0
30	adjuvant	adjuvant	B-NP	JJ	O	31	NMOD	0
31	chemotherapy	chemotherapy	I-NP	NN	O	29	PMOD	19	chemotherapy
32	,	,	O	,	O	31	P	0
33	which	which	B-NP	WDT	O	31	NMOD	0
34	works	work	B-VP	VBZ	O	33	SBAR	0
35	best	well	B-ADVP	RBS	O	34	VMOD	0
36	with	with	B-PP	IN	O	35	AMOD	0
37	positive	positive	B-NP	JJ	O	40	NMOD	0
38	lymph	lymph	I-NP	NN	O	40	NMOD	0
39	node	node	I-NP	NN	O	40	NMOD	0
40	patients	patient	I-NP	NNS	O	36	PMOD	0
41	.	.	O	.	O	6	P	0

